Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06022029
Title A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (ON-5001)
Acronym ON-5001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OncoNano Medicine, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.